Igen (US) to launch Origen analyser in Japan:
This article was originally published in Clinica
Igen (US) is to launch its Origen analyser in Japan following US release earlier this year. The company will work with Eisai to develop an Origen-based clinical diagnostic system in Japan, says Igen CEO and chairman Samuel Wohlstadter. Igen also has an agreement with Boehringer Mannheim, which owns a worldwide licence to use Igen's Origen-based technology to develop diagnostic instruments and assays. Boehringer hopes to launch an instrument, the prototype of which was shown at Medica in 1994, in Europe within a year and in Japan and the US soon after.
You may also be interested in...
Top 100 Review: The Calm Before The Storm – But Some Medtechs Already Reflect The Ravages Of COVID-19
2019 saw fewer revenues-boosting major acquisitions by top-tier medtechs. Companies that reported after the calendar year-end were the first to see the consequences of the pandemic on their annual figures.
Hikma and Sesen Bio have struck a deal that will see Hikma distribute the Vicineum brand in the MENA region.
By establishing a dedicated consumer healthcare subsidiary, Norgine is hoping it can grow its $200m-plus Movicol laxative brand and take advantage of M&A opportunities in the OTC market.